Trypanosoma cruzi invades synaptotagmin VII-deficient cells by a PI-3 kinase independent pathway.
Chakrabarti
Sabyasachi
S
Section of Microbial Pathogenesis, Boyer Center for Molecular Medicine, Yale University School of Medicine, 295 Congress Avenue, New Haven CT 06510, USA.
Andrade
Luciana O
LO
Andrews
Norma W
NW
D000818:Animals; D002135:Calcium-Binding Proteins / Q000172:deficiency / Q000235:genetics; D002478:Cells, Cultured; D014355:Chagas Disease / Q000469:parasitology; D002867:Chromones / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005347:Fibroblasts / Q000469:parasitology; D008247:Lysosomes / Q000469:parasitology; D008562:Membrane Glycoproteins / Q000172:deficiency / Q000235:genetics; D051379:Mice; D018345:Mice, Knockout; D009025:Morpholines / Q000494:pharmacology; D009419:Nerve Tissue Proteins / Q000172:deficiency / Q000235:genetics; D000081082:Phosphoinositide-3 Kinase Inhibitors; D050857:Synaptotagmins; D014349:Trypanosoma cruzi / Q000472:pathogenicity / Q000502:physiology*
D002135:Calcium-Binding Proteins; D002867:Chromones; D004791:Enzyme Inhibitors; D008562:Membrane Glycoproteins; D009025:Morpholines; D009419:Nerve Tissue Proteins; D000081082:Phosphoinositide-3 Kinase Inhibitors; C494303:Syt7 protein, mouse; D050857:Synaptotagmins; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one